Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study.
about
Update on Guillain-Barré syndromeFrequently asked questions on seven rare adverse events following immunization.Importance of diagnostic work-up of Guillain-Barré syndrome in pregnancy.Association of anti-gangliosides antibodies and anti-CMV antibodies in Guillain-Barré syndrome.CMV-associated encephalitis and antineuronal autoantibodies--a case reportPeripheral nervous system manifestations of infectious diseasesAutoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.Acute flaccid paralysis surveillance: A 6 years study, Isfahan, IranEpidemiology of Guillain-Barré Syndrome in Aruba.Outcome of Guillain - Barré Syndrome in Children: A prospective cohort study in a tertiary hospital in Upper Egypt.A young patient with multisystem complications after cytomegalovirus infection.Recent developments and future directions in Guillain-Barré syndrome.Infectious and noninfectious triggers in Guillain-Barré syndrome.New strategies in the management of Guillain-Barré syndrome.The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.Late-onset cytomegalovirus infection complicated by Guillain-Barre syndrome in a kidney transplant recipient: case report and review of the literature.Hyponatraemia in Guillain-Barré syndrome revisited.Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias.Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.Zika virus-associated Guillain-Barré syndrome: a warning for critical care physicians.Guillain-Barré syndrome following acute co-super-infection of hepatitis E virus and cytomegalovirus in a chronic hepatitis B virus carrier.Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016.HIV positive patient with GBS-like syndrome.Increased incidence of Campylobacter jejuni-associated Guillain-Barré syndromes in the Greater Paris area.Bifacial weakness with paresthesias: Serial nerve conduction studies indicate diffuse demyelinating neuropathy.Zika virus and Guillain-Barré syndrome in Bangladesh.Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaignAutoinflammatory and autoimmune contributions to complex regional pain syndrome
P2860
Q28293098-0022C7CC-5940-4B01-9AE8-DFB402442FB7Q30234430-8077E59A-AE6C-48D8-9EB9-7BCE6F299790Q33437291-C6F6DBF9-5E14-430C-872A-D17895CDD4B8Q33695363-B0FA8B89-8BE2-4216-BB42-6ED395DB46AFQ34402966-73B4DED5-E875-46AF-8600-09262BEC59FAQ34418510-E6A3F2AE-B2E0-4243-90F6-C6C3B7EF2DA4Q34614091-432D9443-BE7D-4FCF-B88C-CAD9EA231D00Q34677183-EC271300-33A3-43C0-9577-B95CCAC8850FQ35615088-7E17270E-C949-4755-A777-E0766EA63323Q36958561-35BA04F2-12CC-4A9C-8AB8-21096ACD1FD8Q37613920-B668C88B-5816-42B9-A5BA-41EBE71C1C4AQ37700839-0B8D7C46-4DF3-4339-938D-39B6E6280F2FQ38070887-68CF1DAC-95D4-4B20-BA6E-5C16171F109AQ38125242-D4C62ACA-6A65-403C-AD27-9FC3B6FFA512Q38140727-F4432BAE-C796-4EA5-95AC-6E144E656B2BQ38529622-DEF7F162-3546-4237-925A-726AC68D19B6Q38542625-14FAA896-B608-40AC-A63F-4F33DF7F0CAAQ38548955-CFDAB2B5-71AB-48ED-9DC3-6948A86DF6DFQ38575588-05BE0491-1038-40FC-A764-3E214011E1F6Q38587703-CCABBDE3-9AF5-4FAA-AD38-0F6C2B9DA92BQ38862736-F0929103-F371-4E3C-9645-F8291EE99502Q40059523-65A8C3B7-982D-4450-8F31-103F8CDEE48AQ40631137-C212F9DC-95FF-42A5-B2D2-6BC1321550F6Q40803936-4193644C-67A6-4778-9C95-6E5F263835D4Q42363071-FCBDEA70-C726-468D-9358-E074AB061FE4Q44317794-9FE3EF1D-5B62-4558-BC85-C46701DDF0F6Q53205536-3D1C9106-320B-440C-9F52-6E04B34FEF5EQ55084470-FFF0BE4D-EA33-4908-8210-645D5BAD7B7FQ56887924-8ABAAAC0-7F73-47EA-B9D0-F6E869A99FCBQ58733893-8D3F36FC-F2B5-4CDD-A969-A9A3E42F00BB
P2860
Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@ast
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@en
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@nl
type
label
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@ast
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@en
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@nl
prefLabel
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@ast
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@en
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@nl
P2093
P356
P1476
Guillain-Barré syndrome follow ...... n: a prospective cohort study.
@en
P2093
Christiane Caudie
David Orlikowski
Djillali Annane
Elyanne Gault
Flore Rozenberg
Jacqueline Roussi
Jean-Charles Quincampoix
Jean-Claude Raphaël
Jean-Louis Gaillard
Marianne Leruez-Ville
P304
P356
10.1093/CID/CIR074
P407
P577
2011-04-01T00:00:00Z